MedPath

苏州二叶制药有限公司

Ownership
-
Established
1981-04-13
Employees
-
Market Cap
-
Website
http://www.szerye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

166

NMPA:166

Drug Approvals

Compound Sodium Picosulfate Granules

Product Name
复方匹可硫酸钠颗粒
Approval Number
国药准字H20253426
Approval Date
Feb 20, 2025
NMPA

Lidocaine and Prilocaine Cream

Product Name
利丙双卡因乳膏
Approval Number
国药准字H20253227
Approval Date
Jan 24, 2025
NMPA

Ceftazidime and Avibactam Sodium for Injection

Product Name
注射用头孢他啶阿维巴坦钠
Approval Number
国药准字H20249702
Approval Date
Dec 6, 2024
NMPA

Oxacillin Sodium for Injection

Product Name
注射用苯唑西林钠
Approval Number
国药准字H20247017
Approval Date
Jan 22, 2024
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20247014
Approval Date
Jan 16, 2024
NMPA

Piperacillin Sodium and Sulbactam Sodium for Injection

Product Name
注射用哌拉西林钠舒巴坦钠
Approval Number
国药准字H20090041
Approval Date
Aug 29, 2023
NMPA

Piperacillin Sodium and Sulbactam Sodium for Injection

Product Name
注射用哌拉西林钠舒巴坦钠
Approval Number
国药准字H20090040
Approval Date
Aug 29, 2023
NMPA

Piperacillin Sodium and Sulbactam Sodium for Injection

Product Name
注射用哌拉西林钠舒巴坦钠
Approval Number
国药准字H20153298
Approval Date
Aug 29, 2023
NMPA

Azithromycin Capsules

Product Name
阿奇霉素胶囊
Approval Number
国药准字H20083315
Approval Date
Feb 21, 2023
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20223859
Approval Date
Nov 15, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.